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Tubular epithelial cells play a central role in the pathogenesis of chronic nephropathies. Previous toxicogenomic studies have
demonstrated that cyclosporine- (CsA-) induced epithelial phenotypic changes (EPCs) are reminiscent of an incomplete epithelial
tomesenchymaltransition(EMT)inaTGF-β-independentmanner.Furthermore,weidentiﬁedendoplasmicreticulum(ER)stress
as a potential mechanism that may participate in the modulation of tubular cell plasticity during CsA exposure. Because c-jun-N-
terminal kinase (JNK), which is activated during ER stress, is implicated in kidney ﬁbrogenesis, we undertook the current study
to identify the role of JNK signaling in EPCs induced by CsA. In primary cultures of human renal epithelial cells, CsA activates
JNK signaling, and the treatment with a JNK inhibitor reduces the occurrence of cell shape changes, E-cadherin downregulation,
cell migration, and Snail-1 expression. Our results suggest that CsA activates JNK signaling, which, in turn, may participate in the
morphological alterations through the regulation of Snail-1 expression.
1.Introduction
Thepathogenesisofcyclosporine(CsA)nephrotoxicityisnot
fullyunderstood,andmanymechanismshavebeenproposed
[1, 2], such as the epithelial to mesenchymal transition
(EMT),aphenomenonthathasbeenimplicatedintheinitia-
tion and development of chronic nephropathies [3–6].
Under the pressure of numerous facilitating factors, tubular
cells can lose their epithelial phenotype, express mesenchy-
mal markers, acquire migratory and invasive potential, and
secrete extracellular matrix. EMT promotes the generation
of myoﬁbroblasts, and growing evidence has implicated this
process in diseased kidneys, leading to renal ﬁbrosis [4, 7–9].
A better understanding of the role of tubular cells and
EMT in the development of kidney ﬁbrosis may lead to the
development of speciﬁc biomarkers of early graft damage
and to the characterization of novel therapeutic targets.
Transcriptomic analysis of tubular cell response to CsA has
shown that CsA induces EMT in vitro in a transforming
growth factor β-(T G F - β-) dependent manner [10]. In a pre-
vious study, we have shown that CsA promotes TGF-β-in
dependent epithelial phenotypic changes (EPCs). However,
we have not observed de novo α-smooth muscle actin (α-
SMA)expression,suggestingthatCsAinducesanincomplete
EMT. In addition, we have identiﬁed the endoplasmic
reticulum (ER) stress as a potential mechanism that may
participate in the modulation of tubular cell plasticity in
CsA-induced EPCs [11]. However, the precise mechanisms
by which CsA promotes EPCs remain elusive.
The signaling pathways that are mediated by c-jun
N terminal kinase (JNK), which is activated during ER
stress following TRAF-2 recruitment and activation through
Ire1 signaling [12], integrate epithelial cell plasticity, cell
migratory potential, and the disruption of cell-cell contact
during morphogenesis [13–15]. Importantly, JNK mediates
kidney ﬁbrogenesis in a mouse model of unilateral ureteral
obstruction[16].Notably,TGF-βandRhoGTPasessignaling
pathways involve JNK [14, 17].
We undertook the current study to test whether JNK
signaling promotes tubular EPCs following CsA exposure.
Here, we demonstrated that CsA activated JNK signaling
in human renal epithelial cells and that JNK inhibition2 Journal of Transplantation
reduced the CsA-induced E-cadherin downregulation, cell
migration, and Snail-1 expression. Our results suggest that
JNK signaling is involved in CsA-induced tubular EPCs.
2.MaterialsandMethods
2.1. Material and Reagents. All chemicals, including CsA,
were obtained from Sigma-Aldrich (Saint Quentin Fallavier,
France). The cell culture medium and the other cell culture
products were from Life Technologies (Cergy Pontoise,
France).
2.2. Cell Culture. Human renal epithelial cells (HRECs) were
culturedaccordingtopreviouslypublishedmethods[18,19].
We used 6 μM CsA as a working concentration because this
concentration did not induce excessive toxicity and pro-
moted EPCs [11]. Moreover, this concentration is similar to
that observed in clinical practice where CsA blood concen-
trations may be measured up to 2μM.
2.3. RNA Extraction and Quantitative Real-Time Polymerase
Chain Reaction. Total RNA was extracted using the RNeasy
Mini Kit (Qiagen, Courtaboeuf, France) following the man-
ufacturer’sprotocol.Transcriptsexpressionlevelswerequan-
tiﬁed using an ABI PRISM 7900 sequence detector system
(AppliedBiosystems,FosterCity,CA,USA).Foldchangesfor
eachtestedgenewerenormalizedtoRibosomalProteinL13A
(RPL13A). The relative expression levels among samples
were calculated using the comparative delta Ct (threshold
cycle number) method with vehicle-treated samples as refer-
ences [20]. The mRNA levels were quantiﬁed in triplicate
using the following primers: E-cadherin sense 5 -TACGCC
TGGACTCCACCTA-3  and antisense 5 -CCAGAA
ACGGAGGCCTGAT-3 ; Snail-1 sense 5 -ACCCACACT
GGCGAGAAGCC-3 and antisense 5 -TTGACATCTGAG
TGGGTCTG-3; RPL13A sense 5 -CCTCGAGGAGAACAG
GAAAGAGA-3  and antisense R5 -GAGGACCTCTGTGTA
TTTGTCAA-3 .
2.4. Protein Extraction and Western Blot Analysis. Total
protein lysates from HRECs were separated by sodium-do-
decyl-sulfate polyacrylamide gel electrophoresis under dena-
turing conditions and transferred to PVDF membranes (GE
Health-care, Aulnay sous bois, France). E-cadherin, pJNK
and JNK were detected using rabbit antibodies (No. 4065,
N◦4668,N◦9252;dilutionsat1:1000or1:100forpJNK;Cell
Signaling Technologies, Saint Quentin en Yvelines, France),
Snail-1 using a rabbit antibody (No. 17732; dilution at
1:500; Abcam, Paris, France) and actin using a rabbit anti-
body(N◦2668,dilutionat1:5000;SigmaAldrich,SaintQue-
ntin Fallavier, France). The membranes were incubated with
a horseradish peroxidase-conjugated polyclonal secondary
antibody (Dako, Trappes, France) followed by ECL reagent
(GE Health care).
2.5. Viability Studies. T h er e l a t i v en u m b e ro fl i v i n gc e l l sp e r
well was determined based on mitochondrial integrity using
the3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphen-
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Figure 1: Cyclosporine (CsA) activates JNK signaling. (a) Repre-
sentative western blot of JNK and p-JNK expression in primary cul-
tures of HRECs exposed to the vehicle or 6μMC s Af o rv a r i o u s
incubation times. (b) Real-time PCR analysis of EGR1 mRNA ex-
pression in cells that were exposed to 6μM CsA with or without the
2μM JNK inhibitor (L)-JNKI1.
yl)-2-(4-sul-fophenyl)-2H-tetrazolium (MTS) assay (Pro-
mega, Charbonnieres, France) according to the manufac-
turer’s instructions.
2.6. Wound Healing. HRECs were grown in plastic coverslips
to 75% conﬂuence and were exposed to 6μM CsA for 48
hours. A straight and uniform scratch was made through the
monolayer with a 200μL plastic pipette tip. The wounded
areasweremarkedandphotographedatdiﬀerenttimepoints.
2.7. Statistical Analysis. All data were expressed as means ±
SEM of three diﬀerent experiments. Biological and histolo-
gicaldatawerecomparedusingnonparametrictests.Weused
the Mann-Whitney test for comparisons between the two
groups. Statistical analyses were performed using Prism 4
software (GraphPad software). P values that were of less than
0.05 were considered signiﬁcant.
3. Results
3.1. CsA Activates JNK Signaling. We previously characteriz-
ed CsA-triggered tubular EPCs and demonstrated that ER
stress was implicated in these changes [11]. To under-
stand how CsA induced EPCs, we focused on JNK
signaling be-cause JNK is activated during ER stress
[21]. It has been shown to modulate cell plasticityJournal of Transplantation 3
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Figure 2: JNK signaling is involved in cyclosporine-induced EPCs. (a) Cellular morphology after 48h exposure to 6μM cyclosporine with
or without 2μM (L)-JNKI1 was determined using phase contrast microscopy. Bar, 4μm. (b). Cell viability was determined using the MTS
assay after 72h exposure to various concentrations of cyclosporine (CsA) with or without 2μM (L)-JNKI1; ∗P = 0.04, n = 4. (c) Real-time
PCR analysis of E-cadherin mRNA expression after 48h exposure to various concentrations of CsA with or without 2μM (L)-JNKI1. (d)
Representative western blot of E-cadherin in whole cell lysates after exposure to vehicle, 6μMC s A ,2μM (L)-JNKI1, and 6μMC s A+2μM
(L)-JNKI1 for 48 hours. (e) Representative phase contrast micrographs of the initial wounding and 12 hours after wound healing (left). Bar,
50μm.4 Journal of Transplantation
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Figure 3: Cyclosporine induces Snail-1 expression in a JNK-dependent manner. (a) Representative western blot of Snail-1 expression in
tubular cells during exposure for various incubation times with 6μMC s Ao r6μM CsA + (L)-JNKI1. (b) Densitometric analysis of Snail-1
expression in three independent experiments. ∗P<0.05 versus control. (c) Real-time PCR analysis of Snail-1 mRNA expression in tubular
cells that were exposed for various incubation times with 6μM CsA with or without 2μM (L)-JNKI1.
and EMT, and is implicated in kidney ﬁbrosis [13, 15,
16]. HRECs that were exposed to 6μM CsA displayed
early JNK phosphorylation (Figure 1(a)). We inhibited
JNK signaling using L-JNKi 1. The L-JNKi 1 repre-
sent the only potent inhibitors speciﬁc for JNK (JNK1,
JNK2, and JNK3). Diﬀerent from chemical inhibitors
that directly aﬀect kinase activity, for example, by competing
with the ATP-binding site of the protein kinase, they rather
inhibit the interaction between JNK and its substrate, result-
ing in a JNK K.O. phenotype [22]. JNK inhibition with (L)-
JNKI1 attenuated the CsA-induced expression of early
growth response 1 (EGR-1) mRNA, which is a JNK-depen-
dent transcription factor [23]. These results suggest that CsA
activates the JNK signaling pathway (Figure 1(b)).
3.2. JNK Signaling Is Involved in CsA-Induced EPCs. CsA-
induced EPCs are characterized by an elongated shape,
the development of lamellipodia, a large degree of cell
detachment,andthedownregulationoftheepithelialmarker
E-cadherin (Figure 2(a) and [24]). To test whether JNK
is implicated in these phenotypic changes, we treated
HRECs with CsA in the presence or absence of the speciﬁc
JNK inhi-bitor (L)-JNKI1. (L)-JNKI1 dramatically reduced
the CsA-induced EPCs (Figure 2(a)), increased cell viabil-
ity (Figure 2(b)), and suppressed CsA-induced E-cadherin
downregulation at the mRNA (Figure 2(c))a n dp r o t e i n
levels (Figure 2(d)). In addition, JNK inhibition reduced
CsA-induced migratory properties of HRECs (Figure 2(e)).
Together, these results suggest that the activation of JNK
signaling by CsA re-gulates the phenotypic changes of
HRECs.
3.3. CsA-Induced Snail-1 Expression Is JNK Dependent. Be-
cause JNK is implicated in CsA-induced EPCs, we tested
whether JNK interacted with transcriptional factors that are
implicatedinEMT.Snail-1,whichrepressestheexpressionofJournal of Transplantation 5
E-cadherin, is a central regulator of EMT. We demonstrated
that CsA induced Snail-1 protein expression as early as one
hour after treatment and that this upregulation was JNK
dependent (Figures 3(a) and 3(b)). Interestingly, Snail-1
mRNA levels were not signiﬁcantly altered by CsA treat-
ment. This result suggests that CsA regulates Smail-1 mainly
at the posttranscriptional level (Figure 3(b)). In addition,
JNK inhibition did not aﬀect the level of Snail-1 mRNA in
CsA-treated cells, suggesting that the repression of CsA-
induced Snail-1 expression is also posttranscriptionally
determined (Figure 3(c)). These results suggest that CsA
posttranscriptionally regulates Snail-1 protein expression in
a JNK-dependent manner.
4. Discussion
In the current study, we showed that tubular cells that were
exposed to CsA acquired phenotypic changes and that JNK
signaling is implicated in this process. We focused on JNK
activation because JNK is activated during ER stress and
modulates cell plasticity at multiple levels. We found that in
our model JNK was transiently activated during CsA expo-
sure and that its inhibition attenuated CsA-induced EPC.
TheexpressionofthemajorE-cadherinrepressorSnail-1was
increased after CsA treatment in a JNK-dependent manner.
CsA induces a complete EMT in vitro through an auto-
crine and/or paracrine action of TGF-β [25]. TGF-β is the
major inducer of EMT during chronic nephropathies, and
CsAinducesTGF-βsynthesisandsecretioninvivo[2].Under
our experimental conditions, CsA exposure did not induce
TGF-β mRNA transcripts, the phosphorylation of Smad2,
nor an alteration of Smad2/3 expression levels [24]. There-
fore, TGF-β signaling was not a major contributor of the
EPCs during CsA exposure in our model.
Ourresultsindicatethatthemodulationofseveralchara-
cteristics of epithelial plasticity is reminiscent of an EMT
and may be integrated by JNK activation during CsA expo-
sure. JNK signaling is activated in various human kidney dis-
eases including diabetic and hypertensive nephropathies
[26]. In experimental models, JNK has been shown to medi-
ate ﬁbrogenesis in unilateral ureteral obstruction and anti-
glomerular basal membrane disease models (16, 26). Most
importantly, JNK inhibition is beneﬁcial in these models
via its anti-inﬂammatory and antiﬁbrotic properties. JNK is
involved in ﬁbrogenesis by mediating TGF-β signaling
[17, 27]. Notably, TGF-β-independent activation of JNK is
involved during EPCs and includes Rho GTPase signaling
[17] and planar cell polarity [28]. Our results based on an
in vitro model should be translated in vivo with caution.
JNK signaling is believed to be a therapeutic target against
ﬁbrosis, and our results encourage further in vivo studies to
test whether JNK inhibition limits the extension of ﬁbrosis
during chronic CsA-induced nephrotoxicity.
We demonstrated that the expression of transcriptional
factor Snail-1 was regulated by JNK signaling. Snail-1 and
Snail-2 (also known as Slug) belong to the Snail superfamily
of zinc ﬁnger transcriptional repressors. They have emerged
as key factors that regulate E-cadherin and the induction
of EMT and are implicated in the pathophysiology of various
human tumors [29]. In experimental kidney diseases, Snail-
1 is overexpressed in renal tubular cells in the unilateral ure-
teral obstruction model, and its expression is posttranscrip-
tionally stabilized by glycogen synthase kinase 3 β (GSK3β)
[30]. Here, we demonstrated that the expression of Snail-1
at the protein level is dependent on JNK signaling during
CsA treatment. JNK is known to regulate Snail-1 expression
at the transcriptional level via the AP-1 transcription factor
complex,whichisadownstreamtargetofJNKsignaling[31].
However, the mechanisms by which JNK increases Snail-1
protein expression remain to be established.
In conclusion, our results demonstrate that CsA activates
JNK signaling in tubular cells, leading to epithelial pheno-
typic changes. The result that JNK inhibition reverses this
phenotype implicates JNK as a potential therapeutic target
for the development of novel nephroprotective strategies.
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